Ozempic 2 MG/dose (8 MG/3 ML) 3ML
Ended Awarded Last action
- Contract number
- SPE2DR26F3VBG
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,397
Award facts
- Contract value 100% obligated
- $14,397.23 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $14,397.23 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 ml) in 3 ml vials. The contract was awarded on February 4, 2026, with an ultimate completion date of February 5, 2026, and carries no set-aside designation, indicating it was competitively awarded. The place of performance is listed as Conshohocken, Pennsylvania, which is AmerisourceBergen's corporate headquarters location. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 and extending through December 31, 2031, which serves as the primary vehicle for supplying comprehensive pharmaceutical and medical supplies to military healthcare programs globally.
AmerisourceBergen Drug Corp functions as a critical pharmaceutical distributor within the federal medical procurement system, supplying brand-name and generic medications, vaccines, and specialized healthcare commodities across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This specific order for Ozempic, a diabetes management medication, reflects the company's established capability to fulfill federal medical supply needs across varied product categories and order values. The non-set-aside, competitively awarded nature of this delivery order demonstrates AmerisourceBergen's continued qualification to meet federal pharmaceutical procurement requirements through open competition.
Quick answers
Who was awarded contract SPE2DR26F3VBG?
SPE2DR26F3VBG was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on February 4, 2026.
How much is contract SPE2DR26F3VBG worth?
The government has obligated $14,397 on SPE2DR26F3VBG.
Is contract SPE2DR26F3VBG an order under another contract?
Yes. SPE2DR26F3VBG is a delivery order under SPE2DR25D2104, an indefinite delivery contract.
Was contract SPE2DR26F3VBG competed?
The extent of competition for SPE2DR26F3VBG was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award